Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 29, 2021 - Novartis announced the FDA approval of Scemblix (asciminib).
Return to publications